2015-present: PhD candidate
University College London, London, UK.
Department of Neuroinflammation · Institute of Neurology
2005-2012: Medical Doctorate Degree (M.D.). GPA: 17 out of 20·
Tehran University of Medical Sciences, Tehran, Iran.
School: Medical School
Thesis: Structural substrate for resting-state network changes in neuromyelitis optica and their distinction from multiple sclerosis Description: My thesis used DTI and high-resolution structural data (T1) to explore underlying causes for resting-state fMRI changes in neuromyelitis optica (NMO) and whether these alterations could distinguish between NMO and MS.
Advisors: Mohammad Ali Sahraian & Amirreza Azimi
High School Dr. Hesabi High School, Tehran, Iran
1. Eshaghi A, Riyahi-Alam S, Saeedi R, Roostaei T, Nazeri A, Aghsaei A, Doosti R, Ganjgahi H, Bodini B, Shakourirad A, Pakravan M, Ghana’ati H, Firouznia K, Zarei M, Azimi AR, Sahraian MA. Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis. Neuroimage: Clinical. 2015; 7:306-314. 2. Weier K, Eshaghi A, Magon S, Andelova M, Radue EW, Kappos L, Azimi AR, Sahraian MA, Sprenger T. The role of cerebellar abnormalities in neuromyelitis optica - a comparison with multiple sclerosis and healthy controls. Multiple Sclerosis Journal. 2014. 3. Eshaghi A, Bodini B, Ridgway GR, Garca-Lorenzo D, Tozer DJ, Sahraian MA, Thompson AJ, Ciccarelli O. Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis. NeuroImage. 2014;86:257-264. 4. Eshaghi A, Riyahi-Alam S, Roostaei T, Haeri G, Aghsaei A, Aidi MR, Pouretemad HR, Zarei M, Farhang S, Saeedi R, Nazeri A, Ganjgahi H, Etesam F, Azimi AR, Benedict RH, Sahraian MA. Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS). __The Clinical Neuropsychologist__. 2012;26(6):975-984. 5. Sahraian MA, Radue EW, Eshaghi A, Besliu S, Minagar A. Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis. European Journal of Neurology. 2012;19(8):1060-1069. 6. Sahraian MA, Eshaghi A. Role of MRI in diagnosis and treatment of multiple sclerosis. Clinical Neurology and Neurosurgery. 2010;112(7):609-615. 7. Sahraian MA, Eshaghi A. Concomitant multiple sclerosis and idiopathic thrombocytopenic purpura. European Journal of Neurology. 2010;17(8):e62-63.
Lyon, France 2012 · Dynamic changes in grey matter volume over 5 years in Primary Progressive Multiple Sclerosis: a tensor-based morphometry study. 2012 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress.
Copenhagen, 2013 · Structural substrates for resting-state network changes in neuromyelitis Denmark optica and their distinction from multiple sclerosis. 2013 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress. Young Investigator’s Session